Tessa Therapeutic (Singapore)

Recent papers from Tessa Therapeutic (Singapore)

1. Unlocking extracellular vesicle-mediated efficient DNA delivery for long-lasting transgene expressionMolecular Therapy · 2026
2. A phase 1, open-label study to determine safety and tolerability of the topical application of mesenchymal stem/stromal cell (MSC) exosome ointment to treat psoriasis in healthy volunteersCytotherapy · 2025
3. Piloting a scale-up platform for high-quality human T-cells productionFrontiers in Cell and Developmental Biology · 2024
4. Novel OX40 and 4-1BB derived spacers enhance CD30 CAR activity and safety in CD30 positive lymphoma modelsMolecular Therapy · 2024
5. Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and EfficacyCancer Immunology Research · 2024
6. B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid TumorsCancer Research Communications · 2024
7. Abstract P66: Off-The-Shelf Epstein Barr Virus Specific T Cells Armored with B7-H3-Targeting Chimeric Antigen Receptors Is an Effective and Safe Tumor- Agnostic Therapy For B7-H3 Positive Solid MalignanciesCancer Research · 2024
8. Abstract P65: Single Cell Profiling Reveals Unique TCR Repertoire and Transcriptomic Signatures of Epstein-Barr Virus-Specific T cells (EBVSTs) Armoured with Chimeric Antigen Receptors (CARs)Cancer Research · 2024
9. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles · 2024
10. A novel GPI-anchored dominant-negative TGF-β receptor II renders T cells unresponsive to TGF-β signalingMolecular Therapy — Oncolytics · 2023
11. Cord blood–derived V δ 2 ⁺ and V δ 2 ⁻ T cells acquire differential cell state compositions upon in vitro expansionScience Advances · 2023
12. In Vitro Study on AI‐PRS Enabled Precision Cocktail Drugs Design for Treating Human Colorectal CarcinomaAdvanced Therapeutics · 2023
13. An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphomaScience Translational Medicine · 2022
14. Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancerEuropean Journal of Cancer · 2021
15. Bayesian analysis of cytokines and chemokine identifies immune pathways of HBsAg loss during chronic hepatitis B treatmentScientific Reports · 2021
16. Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Therapy in Nasopharyngeal CarcinomaMolecular Therapy · 2020
17. Electroporation of NKG2D RNA CAR Improves Vγ9Vδ2 T Cell Responses against Human Solid Tumor XenograftsMolecular Therapy — Oncolytics · 2020
18. A novel strategy for single-cell metabolic analysis highlights dynamic changes in immune subpopulations2020
19. TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent MannerFrontiers in Immunology · 2019
20. Extracellular vesicles yield predictive pre‐eclampsia biomarkersJournal of Extracellular Vesicles · 2017